19h
GlobalData on MSNAardvark prices $94.2m IPO to fund development of Prader-Willi syndrome drugAardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.
Katie Price's son Harvey starts Ozempic injections to manage rare genetic condition - Harvey is diagnosed with Prader-Willi ...
Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...
Proceeds will support testing of drugs designed to suppress hunger in people with the tough-to-treat rare disease and, ...
Katie Price has opened up about Harvey's ongoing health issues as she has become forced to turn to weight loss injections for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results